CRP and hemophagocytic syndrome: The MAS-HLH indexes including fever, cytopenia, CRP level, and hyperferritin were significantly improved in one week (P values were 0.001, 0.020, < 0.001, 0.025, respectively); the size of the spleen and the level of sCD25 were significantly decreased in one month (P values were 0.047 and 0.024, respectively) after dabrafenib administration.